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 In Sub-Saharan Africa the prevalence of depression is twice as high in people living with HIV compared to 
those without HIV, as is the case globally (Brandt, 2009; Chibanda, Benjamin, Weiss, & Abas, 2014; Ciesla & Roberts, 
2001). Zimbabwe has a prevalence of HIV of 14.6% and the prevalence of depression  among adults with HIV is 
estimated to be 68.5% (Chibanda, Cowan, Gibson, Weiss, & Lund, 2016). As shown in systematic reviews and a meta-
analysis, depression is one of the most important individual-level factors that adversely affects adherence to 
antiretroviral therapy  (Langebeek et al., 2014; Gonzalez, Batchelder, Psaros, & Safren, 2011). Antiretroviral therapy 
(ART) adherence is the key driver to viral suppression, delaying progression to AIDS and reducing the likelihood of 
transmitting HIV to others (Chi et al., 2009; Cohen et al., 2011). Good adherence is critical for survival and for 
achieving the goal set by the Joint United Nations Programme on HIV/AIDS of 90% of people receiving ART having 
viral suppression by 2020 (Joint United Nations Programme on HIV/AIDS, 2015). Depression may affect adherence 
because it interferes with critical factors like information processing and problem-solving (Fisher, Amico, Fisher, & 
Harman, 2008; S.A. Safren et al., 2012).  
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A systematic review suggested  that the treatment of depression can improve adherence to ART (Sin & 
DiMatteo, 2014).  A recent randomized controlled trial (RCT) in the United States showed that antidepressants alone 
did not improve adherence (Pence et al., 2015), but other RCTs in high income countries (HICs) have shown that 
psychological interventions that integrate cognitive behavioral therapy for depression with adherence counselling 
can improve depression and ART adherence (Safren et al., 2015; Safren et al., 2012; Simoni et al., 2013). While these 
interventions have been developed and tested in high income HIC settings, they may have similar results in low and 
middle-income countries (LMIC) LMIC settings and be able to be taken to scale. There is preliminary evidence to 
suggest the acceptability and feasibility of this approach in South Africa (Andersen et al., 2016). However, especially 
in low-income countries such as Zimbabwe, it is important that interventions are feasible for non-specialists to 
deliver. A task-shifting approach has been recommended, by which non-specialists take on tasks that in high-income 
settings are normally provided by mental health specialists. Task-shifting for depression can be delivered through a 
stepped-care model by which clients are all offered  a low-intensity treatment in the first instance, only 'stepping up' 
to intensive or specialist services as clinically required (Haaga, 2000). 
In prior work, we described the initial phases of culturally and linguistically adapting a problem solving 
therapy-based intervention for ART adherence among people living with HIV (PLWH) in Zimbabwe (‘Nzira Itsva’ or 
‘New Map’) (Bere et al., 2016), based on the original Life-Steps intervention (Safren et al., 2004). As a subsequent 
phase of this work, we sought to integrate Nzira Itsva with therapy for depression to address depression and ART 
adherence simultaneously. To integrate with Nzira Itsva, we picked a culturally adapted problem-solving therapy 
(PST) for depression and behavioural activation, known locally as ‘Opening up the Mind’ or Kuvhura Pfungwa (Abas 
et al., 2016). PST is a brief evidence-based therapy for depression in which patients are taught a structured approach 
to identifying problems and finding workable solutions (Mynors-Wallis, 1996; D'Zurilla & Nezu, 2007).  Depression 
may affect adherence because it interferes with critical cognitive and emotional correlates like information 
processing and problem-solving (Safren et al., 2012, Fisher et al., 2008).  The World Health Organisation is currently 
developing PST as part of its task-shifting toolkit for dealing with depression in low- and middle-income countries 
(Lima et al., 2009). This forms part of the stepped-care guideline: The Mental Health Gap Action Plan (mhGAP)(WHO, 
2016).  





The aim of this study is to assess the feasibility and acceptability of a culturally adapted, integrated 6-session 
psychological intervention based on PST and delivered by adherence counsellors to address ART adherence and 
depression among PLWH receiving care in a general clinic setting in Harare, Zimbabwe and to examine preliminary 
changes in depression following the adapted intervention. Three cases will be presented in this paper to show how 
this intervention can be implemented in routine HIV care. 
Methods 
Setting 
All participants were recruited from Parirenyatwa General Hospital which has a large ART clinic in central 
Harare that provides ART to approximately 3000 patients and is a referral centre for complicated HIV management. 
When we initiated the intervention, there was no specific care at the clinic for depression. Only patients with 
suspected severe mental disorder could be referred to the psychiatrists. 
Recruitment  
We recruited participants with adherence problems for an open-label pilot trial through a number of 
methods which included referral from doctors, announcements in the waiting hall and in appointment queues.  
During the announcements, the research assistant gave a brief synopsis of the research study and asked that people 
with adherence problems who were willing to be screened come to the study room. An information sheet on the 
study was given to the participants and then informed consent was sought from the interested participants.   
Participants who met eligibility criteria and provided informed consent were given a baseline assessment and 
received the intervention.  
Participants 
Participants were included if they were aged 18 or over; had been on ART for at least 4 months as confirmed 
by pharmacy records and medical records; had adherence problems as assessed by one or more of the following: 1) 
one or more missed HIV clinic appointments in past 3 months, 2) referral from doctors due to falling CD4 count or 
detectable viral load or 3) self-reported adherence problems; and had probable depression as assessed by scoring 5 
or above on the short version of the Shona Self Report Questionnaire (SRQ-8) (Patel & Todd, 1996) and through 
interview by a Shona-speaking clinical psychologist.  





Participants were excluded if they had severe cognitive impairment defined as a score of ≤6 on the 
International HIV-Dementia Scale (IHDS) (Sacktor et al., 2005); hazardous alcohol use defined as a score of ≥5 on the 
short AUDIT-C screen for alcohol dependence (Bohn, Babor, & Kranzler, 1995); suicidal intent as determined by the 
P4 screener (Dube, Kurt, Bair, Theobald, & Williams, 2010) or were too unwell/agitated to take part. 
Assessments  
Acceptability. This was defined as participant therapy session attendance.  
Depression symptoms. These were assessed using the Shona Self Report Questionnaire (SRQ-8) which 
assesses common mental disorders that include depression.  The SRQ-8 is a questionnaire consisting of 8 questions 
that was developed and validated in Zimbabwe with a cut-point of 5 and above indicating probable depression (Patel 
& Todd, 1996). 
The supervising psychologist went through the scores to confirm the diagnosis. The SRQ-8 was administered 
by the research assistant at baseline and after 6 months. At Session 4 and Session 6 the SRQ-8 was administered by 
the adherence counsellor. 
ART adherence. This was measured using a real-time electronic adherence monitor called Wisepill (Wisepill 
Technologies, Cape Town, South Africa). Wisepill was used for 14 days at baseline and at 6 month follow up. Wisepill 
is a pill case, which looks like a cell phone and contains an SMS microchip that sends a signal to the Wisepill server of 
the date and time of each opening. The score is the percentage of pills taken on time (+/- 1 hour) over the past 14  
days. To supplement Wisepill, self-reported ART adherence was also assessed using the AIDS Clinical Trials Group 
questionnaire (Chesney et al., 2000), which assessed any missed ART doses in the last 30 days.  
HIV care-related outcomes were extracted from clinic records, including viral load and CD4 count, which were 
measured by routine clinic blood test monitoring. Undetectable viral load was defined as less than or equal to 200.  
A trained research assistant collected the study data whhich was entered using REDCap electronic data capture tools 
hosted at the University of Zimbabwe, College of Health Sciences. The dataset was exported to Stata v14.0 for 
analysis.  Ethical approval was obtained from the Medical Research Council of Zimbabwe (MRCZ/A/1936), the Joint 
Parirenyatwa Hospital Ethics Committee (JREC 18/13) and King’s College London College Research Ethics Committee 
(PNM/13/14-158). Participants were reimbursed ($3) for travel and provided with a snack.  
The Intervention 





Insert Table 1 here. 
The intervention was delivered by one adherence counsellor. Her educational qualifications were 5 subject 
passes in 11th grade. She had worked as a nurse aide and then did 6 months training in adherence counselling.  She 
had 5 years of experience working as an adherence counsellor. She had received 5-day training in the culturally 
adapted, integrated behavioural intervention (Nzira Itsva). A local psychologist (TB) provided her with weekly face-
to-face supervision.  
The culturally adapted intervention was based upon problem-solving therapy (PST) for depression and 
adherence. The underlying assumption of this approach is that mental distress can be understood as the negative 
consequences of ineffectual or maladaptive coping strategies. PST assists individuals to adopt a more realistically 
positive perspective of coping, recognise the role of emotions more effectively, and develop action plans geared 
towards reducing distress and enhancing well-being. (D'Zurilla & Nezu, 2007; Lima et al., 2007; Nezu, 2004). PST does 
not require extensive training for delivery or complex skills from the therapist, and can therefore be delivered by lay 
counsellors using a task sharing approach. The 6-session intervention consisted of 1 session for PST for adherence 
barriers and then 5 sessions for PST for depression with some time spent at each session also reviewing adherence 
(Table 1). The first two sessions each take up to 50 minutes; sessions 3-6 last up to 30 minutes.  
Session 1 - Nzira Itsva (‘New Direction’). 
LifeSteps is a an adherence intervention based on cognitive behavioral principles that identifies barriers to 
ART medication adherence and uses a problem solving approach to identify potential solutions (Safren et al., 2001). 
The first session is Nzira Itsva (New Map) (Bere et al., 2016), the culturally and linguistically adapted Life-Steps 
adherence intervention (Steven A Safren, Otto, & Worth, 1999; Steven A Safren et al., 2001), a detailed description 
of which can be found elsewhere (Bere et al., 2016). LifeSteps is a an adherence intervention based on cognitive 
behavioral principles  and uses a checklist to identify barriers to ART medication. The primary components include 
psycho-education, enhancing motivation for adherence, and teaching problem-solving skills to address culturally 
relevant barriers to adherence. 
The subsequent five sessions follow the culturally adapted PST intervention for depression (Abas et al., 2016; Dixon 
Chibanda et al., 2011). This approach includes psycho-education about depression (information, advice and support) 
combined with problem-solving, positive activity scheduling, stress management and a 10-15 minute discussion of 





adherence during each session, checking progress and assisting the participant to find solutions for additional 
barriers to adherence.   
Session 2: Problem Solving for Depression. 
Session 2 includes the following components:  
Stage 1: The counsellor explains to the participant the meaning of their SRQ-8 scores.  
Stage 2: The counsellor explains depression as a mental health condition, normalising depression and 
providing information about evidence based interventions including psychological therapy and antidepressants.  
Stage 3 “Kuvhura pfungwa/ (Opening up the mind)”: The counsellor helps the participant understand what is 
happening in their lives, encouraging them to share what is going on and how they feel about it. The aim is to 
identify and formulate the nature of problems being experienced that could be contributing to the depressed mood. 
The adherence counsellor elicits, listens to and reflects back the problem list. The participant is then encouraged to 
categorise and rate each problem in terms of its importance and potential solvability, which supports them to take 
control of their problems and determine what is important to them. Next, patient and counsellor brainstorm a list of 
possible solutions.  
Stage 4: Kusimudzira (encouraging): The participant is encouraged to consider the pros and cons of potential 
solutions. The counsellor helps them recognise potentially dysfunctional problem-solving style activities and helps 
them develop a SMART (Specific; Measurable; Achievable; Realistic; Timely) plan for the successful resolution of 
specific problems. 
 
Stage 5: Kusimbisa (Strengthening): The participant is reassured and encouraged that the goals set can be 
achieved and discouraging certain attitudes or beliefs, which may inhibit or interfere with implementing the action 
plan. The participant is encouraged to see how depression and their problems might also have been contributing to 
non-adherence.  
Session 3: Problem Solving Review. 
The counsellor reviews progress with problem-solving solutions. If the participant reports that the plan went well, 
the counsellor praises, reinforces and reaffirms the plan. The counsellor also explores whether the participant 
wishes to work on identifying and generating solutions for additional problems. If the implementation plan did not 





go well, the counsellor explores the possible reasons for this, unpacks potential obstacles, which may have arisen 
and repeats the various problem-solving tasks in order to determine where renewed efforts should be directed in 
order to solve the problem successfully.  
Session 4: Positive Activity Scheduling and Deep Breathing. 
This session introduces use of positive activities (‘Kusimudzira’) and social support networks to increase 
positivity and help improve mood and functionality. Here participants are encouraged to identify and schedule 
pleasant activities and task-oriented activities, particularly tasks that they have stopped or been avoiding because of 
depression. They are also urged to identify particular resources (individuals, agencies etc.) that may be able to offer 
potential practical or emotional support.  
Sessions 5-6: Review and Relapse Prevention.   
These sessions continue to support clients’ application of problem solving, activity scheduling, relaxation 
exercises and addressing barriers to ART adherence following roughly the same format as session 3. The final session 
incorporates a depression relapse prevention component, which involves identifying personal warning signs of 
relapse, assessing participants’ knowledge of strategies to prevent relapse and identifying future goals. 
For patients failing to make progress after Session 3 or who remained depressed at Session 6, the counsellor could 
refer to the supervising psychologist for assessment and further treatment. The psychologist then provided extra 
support to the counsellor, or delivered the session together with the adherence counsellor or referred the patient to 
get an antidepressant from the clinic and this is the stepped care part of the intervention. 
Results 
We present detailed case histories for three participants to illustrate the application of the intervention. The 
supervising psychologist reviewed the cases to confirm the diagnosis. 
Case 1 
Herbert * was a 49 year old male, married with six children. He did not complete the final year of secondary 
school and had worked as a security guard for over 20 years, but became unemployed after the firm closed down. 
He was taking first line HIV medication and had been on ART for three years.  He self-reported missing ART doses in 
the past 3 months.  





He suffered from minor depression. Symptoms included sadness, thinking too much, poor appetite, fatigue, loss of 
interest and thoughts that he was a failure. Only some of his symptoms were present more than half the days in the 
previous month. His main stressors were financial problems, and worry about a blood test advised by his doctor that 
would cost USD10 which he could not afford. His fear was that the advice to have this test (which was actually just a 
routine test to monitor urea and electrolytes) meant that the doctor thought his liver was failing, because his HIV 
medication was “working against him”.   
During Session 1, the main adherence barrier he identified was forgetting to take medication. He stored his 
medication in a bag that he sometimes forgot to open, and his phone alarm reminder often failed due to lack of 
battery power.  A second barrier was medication side effects, especially nausea.  He made a plan to put stickers on 
his drug storage bag, to remind him to take his ART, charge his phone, and to write down questions for his doctor 
about side effects.  
During Session 2, he prioritised working on the problem of finding USD10 for the blood test. He generated three 
solutions: finding a job as a security guard, buying goods in Lesotho to set up small-scale trading in Zimbabwe, or 
requesting the money from his eldest son. He decided to find a job as a security guard by visiting security firms to 
show his CV and request work. His actions were reviewed in Sessions 3 and 4. He had visited several firms and being 
offered an interview by one. He had also been offered a one-off piece of manual work which would earn enough for 
the blood test.  He was remembering to take his ART with use of the stickers and phone alarm. During Session 5 it 
emerged that he had surrendered the money he had earned to cover a relative’s funeral expenses. Further he had 
not been called back after his job interview.  
 
He could not generate a new solution he thought was feasible. The counsellor referred him for Step 2 care of review 
by a clinical psychologist. The psychologist encouraged him to think of more solutions and he decided to try 
employment agencies and also to ask his son for the blood test money.  At Session 6 he reported that his son had 
given him funds for the blood test, and that he had an appointment at an employment agency.    
Case 4 
Gift* was a 45 year old male, unemployed and married with one child, who had been on ART for 9 years and 
was currently taking second line HIV medication.  He suffered from major depression. Symptoms included loss of 





interest, isolating himself from other men, feelings of being a failure, poor sleep, weight loss, repetitive worries 
about physical health and loss of hope. 
He had suffered from tuberculosis in the past and had been told that he needed an operation. He had given up all 
hope in life because he could not afford the operation. He was also worried that he could not financially take care of 
his wife and child. He had stopped taking his ART medication a few weeks before recruitment into the study. He said 
he knew the consequences of not taking medication and felt like his behaviour was like “knitting a jersey and then 
undoing the stitches”.  
In Session 1, the counsellor reviewed his stressors and helped him understand that taking ART was a step he could 
take to improve his health, even if he could not afford the operation. He opted to re-start his ART and planned to set 
an alarm and ask his wife to remind him to take ART. 
By the second session, his self-reported adherence had improved to 100%. He identified financial problems as his 
priority. He selected becoming an agent in mobile banking for a local telecommunication company as his solution. To 
do this he had to go to the telecommunications company to sign up. In the third session, the counsellor reviewed the 
solution and it had not worked because he did not have enough capital required by the telecommunications 
company. The client then tried a different solution: to cook and sell traditional food for lunches at a local business 
centre. During Sessions 4-6, reviews showed that he was making good progress with this solution. He was less 




Sarah* was a 41 year old widowed female with primary school education and 2 children. She was self-
employed rearing and selling chickens. She was taking first line HIV medication and had been on ART for 8 years. She 
suffered from major depression. The symptoms were poor sleep, sadness, loss of interest, irritability, and poor 
concentration, lasting for several months. The main stressors were family conflict and desire to find a partner. She 
self-reported missing some ART doses in the last week. 
During Session 1 the primary adherence barrier she identified was coping with side effects. She was on a tenofovir, 
lamuvidine and efavirenz regimen and thought it was causing some of her anger towards her children. Sarah came 





up with the solution to talk to doctors and use a future session to learn about anger management. The second 
adherence barrier was forgetting to take her medication in the evening because she would be busy and tired. She 
came up with a solution to set an alarm for her evening medication. The third barrier was fear of taking medication 
after missing a dose, and as a solution to this, she talked to the doctors.  She also identified missing appointments 
due to financial constraints and she decided to continue working on her small business that she was giving up on. 
During Session 2 she and the counsellor discussed anger management techniques, including taking a step back, 
thinking about what she would say, and counting to ten before reacting.  
During Session 3 she reported still feeling depressed. She generated a solution to ask the doctors about the 
possibility of her mood being affected by her medication since her regimen had been changed that month.   
During Session 4 attending church was Sarah’s positive activity. She made a plan to start going to church again. 
During Session 5 the client reported that church had gone well and she planned to continue attending and try to 
participate in more social activities, such as participating in church activities. The counsellor continued with psycho-
education about depression and anger management.  
During Session 6, the client reported some improvement in mood and anger. The patient was doing relatively well 
however at the 6 month follow up visit her depression scores had risen slightly. The participant did not attribute the 
depression symptoms to any life-event, but indicated that this could have been because of her medication regimen. 
Insert Figure 1 here 
Insert Table 2 here 
 
Discussion 
This study provides one of the first examples of a combined intervention to treat depression and address 
barriers to ART adherence in a resource-limited, sub-Saharan African setting.  We used a stepped care intervention 
for depression, integrated with a culturally adapted version of an adherence intervention shown to be feasible, 
acceptable and effective in the USA (Safren et al., 2009).   
The intervention was acceptable to participants as evidenced by their attendance to all 6 sessions and this is 
representative of the participants who received this intervention. This attendance was exceptional considering that 
the participants were given very minimum incentives because only travel to the clinic was reimbursed. A possible 





reason for this high attendance to sessions could be that the participants viewed the intervention as helpful to them 
and attending the session would be an opportunity to review their progress from the previous problem solving 
session. The sessions were also scheduled at an agreed time that was convenient for the participant and this could 
have played a role in the high attendance to sessions. The intervention was also feasible. An adherence counsellor 
with a basic 6-month certificate in adherence counseling was able to deliver the intervention after being trained. The 
certificate in adherence counseling is a qualification that consists of basic training in HIV adherence counselling   
For all the cases presented here, the participant and the counsellor were able to work collaboratively to brainstorm 
and identify barriers and generate solutions to those barriers. This is because the intervention is delivered in a 
collaborative approach with the participant actively involved. The goal is that the participants can apply the skills 
they learned in the sessions even after they had completed the intervention sessions.  
Another reason why the collaborative approach worked well is because both the Nzira Itsva intervention and 
the Problem Solving therapy were culturally and lingusitically  adapted and are appropriate to be used in this setting 
(Bere et al., 2016). Therefore these two combined provide an intervention that adherence counsellors can deliver 
and that participants can learn and implement in their day to day lives. One challenge in implementing this type of 
intervention is in emphasising the collaborative approach that the counselors must use. Generally, in this setting the 
adherence counsellor is trained to “instruct” the patients so that they adhere to medication. Training the adherence 
counsellor as well as checking fidelity of the counselling sessions ensured that this collaborative appraoch was 
maintained.  
Strengths of this study include the cultural adaptation of evidence-based interventions that can be delivered 
by lay counsellors in this resource-limited setting, a focus on missed visits in addition to adherence to promote  
engagement in care, integration of problem solving strategies for both adherence and depression and a 
stepped care model, which provides a parsimonious approach to treatment.  This study has also indicated some 
promising outcomes regarding a change in depression symptoms for people living with HIV. This intervention is of 
public health relevance because in order to achieve the 90% target of those with HIV virally suppressed (Joint United 
Nations Programme on HIV/AIDS, 2015), depression has to be addressed in order to improve adherence.  Other 
areas that could use this model are other chronic illnesses in which adherence to medication is an important part of 
treatment for example is diabetes.  Future studies can be conducted to determine whether the intervention is 





effective for clinical levels of depression, including major depressive disorder, as well as distress. Since depression is 
highly prevalent in people living with HIV clinicians should incorporate depression screening and implement 
subsequent interventions for patients who are depressed.   
In summary, this pilot study suggests that interventions which integrate depression treatment with collaborative 
problem-solving around barriers to adherence can be associated with improved outcomes in both depression and 
adherence. Though this was not an effectiveness study we can say with caution that the findings are consistent with 
the evidence from high income countries that depression can be treated in PLWH (Sherr, Clucas, Harding, Sibley, & 
Catalan, 2011). This is consistent with the most recent WHO guidelines which recommend an integration of 
depression screening and management in routine care for people living with HIV (WHO, 2016). In light of these 
findings a larger randomized effectiveness-implementation trial is warranted. 
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Tables and Figures 
Table 1. Description of Integrated Intervention  for Adherence and Depression 
 Name Components 
Session 1 Nzira Itsva (New Direction) 
Adherence Intervention 
 Psycho-education 
 Identification of barriers to adherence 
 Motivation to take medication 
Session 2 Problem Solving Therapy  Explanation of depression scores and psych-
psychoeducation about depression 
 Identification of the problem 
 Brainstorming and evaluation of solutions 
 Identify one solution to work on 
Session 3 Problem Solving Review  Review of progress on the implementation of solution 
from previous session 
 Identify barriers faced and discuss solutions 
 Possible identification of another problem to work on 
Session 4 Positive Activity Scheduling  Identification of positive activities that the participant 
can engage in 
Session 5 
and 6 
Review and Relapse 
Prevention 
 Support application of problem solving 
 Encourage continuation of positive activities 
























Table 2. Participant characteristics and outcomes 
  Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Case 7 Case 8 Case 9 
Gender  Male Female Femal
e 
Male Male Female Female Male Female  























































 6 6 6 6 1 6 6 6 6 
Self-report 
% pills 
taken   
Baselin
e 
100 100 100 100 100 71.4 85.7 100 100 
Follow-
up 





100 100 96.7 93 100 - - - 100 
Follow-
up 







































Never Never Never Never 
CD4 Baselin
e 
354 243 657 633 28 273 604 - 398 
Follow-
up 





<200 150000 <200 <200 - - 
Follow-
up 
<200 <200 27000 <200 <200 <200 <200 <200 <200 
SRQ-8 Baselin
e 
6 6 6 7 5 7 5 5 4 
Session 
4 
1 6 1 7 - 7 0 1 3 
Session 
6 
2 1 4 5 - 4 0 1 0 
Follow-
up 
2 1 0 4 4 4 2 0 0 
 
 
 
 
